Magnetic Resonance Imaging Follow-up on Temporomandibular Arthritis in Children With Juvenile Idiopathic Arthritis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00801593|
Recruitment Status : Unknown
Verified December 2008 by University Hospital Tuebingen.
Recruitment status was: Recruiting
First Posted : December 3, 2008
Last Update Posted : December 3, 2008
Children with juvenile idiopathic arthritis (JIA) suffer in up to 87% of the cases of arthritis of the temporomandibular joints (TMJs). Magnetic resonance imaging (MRI) is the only modality for the early diagnosis of TMJ involvement.
Aim of the study is to compare symptoms and clinical findings with MRI and ultrasonography results and to describe the action of the current medication on the arthritis of the TMJs.
|Condition or disease||Intervention/treatment|
|Juvenile Idiopathic Arthritis||Procedure: Steroid injection into the TMJs.|
|Study Type :||Observational|
|Estimated Enrollment :||50 participants|
|Official Title:||Arthritis of the Temporomandibular Joints in Children With Juvenile Idiopathic Arthritis- Pilot Study on Diagnostic Value of Ultrasonography and Magnetic Resonance Imaging and Influence of Drug Treatment|
|Study Start Date :||May 2008|
|Estimated Primary Completion Date :||December 2009|
|Estimated Study Completion Date :||June 2010|
|Children with JIA||
Procedure: Steroid injection into the TMJs.
In case of otherwise noncontrollable TMJ involvement steroids are injected into arthritic TMJs under MRI guidance.
- TMJ arthritis on MRI [ Time Frame: every three to six months from recruitment to end of study ]
- TMJ arthritis on ultrasound [ Time Frame: every three to six months from recruitment to end of study ]
- Action of current medication on TMJ arthritis. [ Time Frame: every three to six months from recruitment to end of study ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00801593
|Contact: Nikolay Tzaribachev, MD||+49707129 ext email@example.com|
|University Children's Hospital||Recruiting|
|Tuebingen, Baden-Wuerttemberg, Germany, 72076|
|Contact: Nikolay Tzaribachev, MD +49707129 ext 84711 firstname.lastname@example.org|
|Principal Investigator: Nikolay Tzaribachev, MD|
|Principal Investigator:||Nikolay Tzaribachev, MD||University Hospital Tuebingen|